PNH and Aplastic Anemia: What's the Connection? | Aplastic Anemia & MDS International Foundation

PNH and Aplastic Anemia: What's the Connection?

Presenter(s): 
Topic(s): 
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aplastic Anemia
Presentation Date: 
Friday, November 6, 2020

Charles J. Parker, M.D., is Professor of Medicine in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, at the University of Utah, the Huntsman Cancer Center Institute and the George E. Whalen Medical Center in Salt Lake City, Utah. Dr. Parker's clinical interests include paroxysmal nocturnal hemoglobinuria and he is among the top PNH researchers in the world. Previously, Dr. Parker served as the President of the International Paroxysmal Nocturnal Hemoglobinuria Interest Group (IPIG) and he is currently Editor-in-Chief of The Hematologist.

Dr. Parker discusses the connection between aplastic anemia and PNH including the diagnostic process, treatment options and prognosis. Approximately 1/3 of all aplastic anemia patients may develop PNH so this webinar will be useful to patients with either (or both) diagnoses.